Losartan and Cognitive Function: What the Evidence Actually Shows
A clinician-level review of losartan's impact on cognitive function, covering mechanisms, trial data, and practical guidance for prescribers and patients.
Losartan V2
21 source-based articles maintained by the HealthRX.com Editorial Team.
21articles
4topic areas covered
Jan 28, 2025latest review
Losartan V2 library
Showing 21 of 21 clinical reviews.
Losartan and Sexual Function: What the Clinical Evidence Actually Shows
An evidence-based look at how losartan affects sexual function in men and women, including erection quality, libido, orgasm, and how it compares to other antihypertensives.
Losartan Appetite & Cravings Changes: What the Evidence Actually Shows
Does losartan affect appetite or food cravings? An evidence-based analysis of losartan's metabolic effects, the LIFE trial, RAAS-appetite links, and what patients should expect.
Losartan Autoimmune Disease Considerations: A Clinical Guide
An evidence-based guide to using losartan in patients with autoimmune conditions, covering immunomodulatory mechanisms, drug interactions, organ-specific considerations, and monitoring protocols.
Losartan Bone Health and Density Impact
A deep dive into how losartan, an ARB used for hypertension and diabetic nephropathy, affects bone mineral density, fracture risk, and skeletal remodeling. Includes clinical trial data, mechanism breakdowns, and dosing context.
Losartan Cancer Risk Signal Review: What the Evidence Actually Shows
A physician-level review of the losartan cancer risk signal, covering meta-analyses, FDA communications, ARB-class data, LIFE trial context, and current prescribing guidance.
Losartan Hair and Skin Changes: What Patients and Clinicians Need to Know
A clinical deep-dive into losartan's documented effects on hair and skin, including alopecia, psoriasiform reactions, and rare dermatologic adverse events, with primary-literature citations and prescriber guidance.
Losartan Liver Function Impact: What Patients and Clinicians Need to Know
A comprehensive, evidence-based review of how losartan affects liver function, including hepatotoxicity risk, transaminase changes, drug-induced liver injury data, and monitoring guidance for clinicians and patients.
Losartan Mental Health and Mood Impact: What the Evidence Says
A guide to losartan's effects on mood, cognition, anxiety, and depression, covering RAAS neurobiology, key trials, and practical prescribing considerations.
Losartan Microdosing Protocols: What the Evidence Actually Shows
A clinical deep-dive into losartan microdosing protocols, standard dosing evidence, off-label use cases, and what the primary literature supports for hypertension, nephropathy, and emerging applications.
Losartan Muscle Preservation Strategies: Clinical Evidence and Protocols
A guide to losartan's role in muscle preservation, covering mechanisms, trial data, dosing protocols, and clinical decision-making for patients with hypertension, CKD, or sarcopenia risk.
Losartan Plateau & Non-Response Troubleshooting
Why losartan stops working, or never worked, and exactly what to do about it. MD/PharmD-level guidance on dose optimization, drug interactions, resistant hypertension workup, and combination strategies, with primary-literature citations throughout.
Losartan Post-Bariatric Surgery Use: What Clinicians Need to Know
A clinician-level guide to losartan pharmacokinetics, dose adjustments, drug interactions, and monitoring protocols after bariatric surgery, with primary-literature citations and a practical decision framework.
Losartan Pre-Surgery Hold Window: When to Stop, When to Resume
Evidence-based guidance on the losartan pre-surgery hold window, including exact timing, hemodynamic risks, guideline recommendations, and safe resumption protocols for patients and clinicians.
Losartan Rebound Effects When Stopping: What Patients and Clinicians Need to Know
Does stopping losartan cause rebound hypertension? A clinical deep-dive covering the physiology of RAAS reactivation, discontinuation risk, tapering protocols, and what the evidence actually shows.
Losartan Renal Protection or Renal Risk: What the Evidence Actually Shows
A detailed clinical review of losartan's effects on kidney function, including renal protection in diabetic nephropathy, acute kidney injury risk, hyperkalemia, and how to monitor patients safely.
Losartan Restarting After Acute Illness: A Clinical Guide
When and how to safely restart losartan after acute illness, including sick-day rules, renal monitoring, and dose titration protocols backed by primary literature.
Losartan Seasonal Use Considerations: A Clinical Guide
How temperature, humidity, activity level, and seasonal illness affect losartan dosing, blood pressure control, and patient safety. Evidence-based guidance for clinicians and patients.
Losartan Sleep Architecture Impact: What the Evidence Actually Shows
A look at how losartan affects sleep stages, REM duration, slow-wave sleep, and sleep-disordered breathing, with primary-literature citations and clinical dosing guidance.
Losartan Travel & Timezone-Shift Protocols: A Clinical Guide
A guide to managing losartan dosing across time zones, during long-haul flights, and in heat-heavy travel environments. Covers pharmacokinetics, blood pressure monitoring, drug interactions, and practical adjustment strategies, with a framework for the conversation to have with a prescriber before departure.
Losartan: What to Expect Week by Week in Your First Month
A week-by-week guide to losartan's first month: when blood pressure starts to drop, what side effects are common, what needs a call to your doctor, and how to read your home readings.